Cargando…
Oncolytic Viruses and Hematological Malignancies: A New Class of Immunotherapy Drugs
The use of viruses for tumour treatment has been imagined more than one hundred years ago, when it was reported that viral diseases were occasionally leading to a decrease in neoplastic lesions. Oncolytic viruses (OVs) seem to have a specific tropism for tumour cells. Previously, it was hypothesised...
Autores principales: | Innao, Vanessa, Rizzo, Vincenzo, Allegra, Andrea Gaetano, Musolino, Caterina, Allegra, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816176/ https://www.ncbi.nlm.nih.gov/pubmed/33704184 http://dx.doi.org/10.3390/curroncol28010019 |
Ejemplares similares
-
Radioprotective Agents and Enhancers Factors. Preventive and Therapeutic Strategies for Oxidative Induced Radiotherapy Damages in Hematological Malignancies
por: Allegra, Andrea Gaetano, et al.
Publicado: (2020) -
Promising Anti-Mitochondrial Agents for Overcoming Acquired Drug Resistance in Multiple Myeloma
por: Innao, Vanessa, et al.
Publicado: (2021) -
New Frontiers about the Role of Human Microbiota in Immunotherapy: The Immune Checkpoint Inhibitors and CAR T-Cell Therapy Era
por: Innao, Vanessa, et al.
Publicado: (2020) -
New Insights into YES-Associated Protein Signaling Pathways in Hematological Malignancies: Diagnostic and Therapeutic Challenges
por: Allegra, Alessandro, et al.
Publicado: (2021) -
Coagulopathy and thromboembolic events in patients with
SARS-CoV-2 infection: pathogenesis and management strategies
por: Allegra, Alessandro, et al.
Publicado: (2020)